Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
about
Optimizing antimicrobial therapy in critically ill patientsCommunity-acquired pneumonia: identification and evaluation of nonrespondersPharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient PopulationsTherapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients.Tazobactam and piperacillin-induced thrombocytopenia: A case report.Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patientsReducing medication errors in critical care: a multimodal approach.Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.High creatinine clearance in critically ill patients with community-acquired acute infectious meningitis.Continuous infusion of piperacillin/tazobactam in septic critically ill patients--a multicenter propensity matched analysis.Continuous versus short-term infusion of cefuroxime: assessment of concept based on plasma, subcutaneous tissue, and bone pharmacokinetics in an animal model.Population pharmacokinetics of ceftolozane/tazobactam in healthy volunteers, subjects with varying degrees of renal function and patients with bacterial infections.Antibiotics and extracorporeal circulation--one size does not fit allProtein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patientsDoes Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.Continuous beta-lactam infusion in critically ill patients: the clinical evidenceScreening of patients with augmented renal clearance in ICU: taking into account the CKD-EPI equation, the age, and the cause of admission.Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approachPopulation Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit.Case-control study of drug monitoring of β-lactams in obese critically ill patients.Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial.Pharmacokinetics of Continuous Infusion Meropenem With Concurrent Extracorporeal Life Support and Continuous Renal Replacement Therapy: A Case Report.Piperacillin concentration in relation to therapeutic range in critically ill patients--a prospective observational study.A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia.Antimicrobial dosing in acute renal replacement.Therapeutic Drug Monitoring of Continuous Infusion Doripenem in a Pediatric Patient on Continuous Renal Replacement Therapy.β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.Antimicrobial use in horses undergoing colic surgery.Current treatment of community-acquired pneumonia.Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.Approaches for dosage individualisation in critically ill patients.Clinical implications of antibiotic pharmacokinetic principles in the critically ill.Antibiotic resistance in cancer patients.Improved treatment of multidrug-resistant bacterial infections: utility of clinical studies.Clinical characteristics of Raoultella ornithinolytica bacteremia.Pharmacokinetic considerations for drugs administered in the critically ill.Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics.The use and risks of antibiotics in critically ill patients.
P2860
Q26999905-C476F0F3-2ACF-4EDB-AEED-13247876F20BQ27002420-8E7F3E5C-72FB-49D4-BCDC-E2BC90FADC9EQ28066877-799560B5-0177-4DC3-82A8-D94B7E02E544Q28080607-5690E26B-5A1E-4601-8CB8-E1F8E5E9C5FCQ30316322-6D1BC24A-B7AD-4B63-95FB-80AE8B5C1597Q33431463-066451CA-7A17-4802-B8A7-48F822848906Q33552161-3A4266AA-84DB-48D0-943F-78CC85E7CA08Q34140686-DB179AE0-2C43-42A3-AB95-2683CC52FEE8Q34274190-D10890C3-8EE7-4973-98CC-06B663A5C4FEQ34327857-578DA0C3-10D1-442E-890A-823F166991E6Q34421906-CF46C587-DB77-4618-A3DC-8E39F67EED7BQ34490565-6CF28A0B-AC91-486A-8A4E-4EDC5BC3E626Q34923002-F034FD34-DE6F-41B3-A801-D9FB68E9A16FQ35004269-60AE299F-754E-4E5E-BAD7-5CA19921AB44Q35091940-9D30C857-AFCA-424C-88A8-A28860ECBC84Q36072500-85601F51-11CC-41DE-97DC-5B8BA95C3BD3Q36287127-426D7D8C-EE06-4C4B-AA8D-A52236F6C797Q36329228-5890AEF8-3E4B-4522-8AB2-48D5FFAE3810Q36376844-10A74430-CDBB-40E8-85EA-0BCE4D189517Q36396195-00163D8E-18EE-4B59-977B-C5905B6CC6C6Q36438971-C2C8465C-D14C-4AA9-BFA8-4003769207DAQ36558332-B90930F8-1DEA-4E9B-B0F8-7550D0E6411CQ36633761-80F54459-3591-44F3-AE30-42A941103861Q36652824-89626B74-9E5F-4C54-8276-F1028D473643Q36760879-2E6027B1-BD99-4BC3-9C5F-F717B57F2E25Q36902744-8DD11E79-15F0-4743-9ECA-000097BE044AQ37252494-5EF3CD6F-57C6-483A-972D-F00790DAF905Q37686607-2C928791-1BA4-48D4-A01E-3D213B0F5B48Q38004063-F9B12A7B-E163-4DA6-A337-0E3617193D1DQ38061198-1E7FBF1A-58AA-4CE3-86B0-D47ACD1A83FFQ38105639-9DB5E41D-E483-4EFE-A49D-23D40808A0E4Q38107537-66EFF185-4F35-4FAA-BA01-677AB2DDCFB4Q38125209-F9C263E4-F984-4166-A48F-143834805A8DQ38138835-D221E8FE-EEB8-42EF-B4B7-5D2E5803AED6Q38212258-CA161D68-7E9B-4C9F-A743-83B42CFBFCEAQ38232197-2A3E050F-7EC9-499D-8521-E73FA1C8871FQ38264795-28243BFD-300F-4BD3-B7FE-6AA476DF6FF9Q38351793-A536E7A2-3AC0-411B-A835-5FE678C2FC40Q38644824-AC6C8E7B-B0DE-4526-A9C2-0F2CE945BEA0Q38767901-3CEFF307-83CC-4F55-BDCC-265C536BCBF7
P2860
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Antibiotics in critically ill ...... pharmacokinetics of β-lactams.
@ast
Antibiotics in critically ill ...... pharmacokinetics of β-lactams.
@en
type
label
Antibiotics in critically ill ...... pharmacokinetics of β-lactams.
@ast
Antibiotics in critically ill ...... pharmacokinetics of β-lactams.
@en
prefLabel
Antibiotics in critically ill ...... pharmacokinetics of β-lactams.
@ast
Antibiotics in critically ill ...... pharmacokinetics of β-lactams.
@en
P2860
P356
P1433
P1476
Antibiotics in critically ill ...... pharmacokinetics of β-lactams.
@en
P2093
Joao Gonçalves-Pereira
Pedro Póvoa
P2860
P2888
P356
10.1186/CC10441
P577
2011-09-13T00:00:00Z
P5875
P6179
1037453353